NCT04517890

Transdermal Lidocaine Administration Prior to Insertion Levonorgestrel-releasing Intrauterine System

Clinical Outcomes of Transdermal Lidocaine Administration Prior to Levonorgestrel Releasing Intrauterine System Insertion in Women Delivered Only by Elective Cesarean Section: a Randomized Double Blinded Clinical Trial

• Status: Unknown
• Phase: N/A
• Study type: Interventional
• Enrollment: 200 (estimated)
• Sponsor: Aswan University Hospital · Academic / Other
• Sex: Female
• Age: 18 Years – 45 Years
• Healthy volunteers: Not accepted

Summary

aims to investigate the effectiveness of Transdermal lidocaine patch for Pain Control During Levonorgestrel Releasing Intrauterine System Insertion in Women Delivered Only by Elective Cesarean Section

Detailed description

Long-acting reversible contraception methods are highly effective methods for reduction of the unplanned pregnancy rate worldwide. The intrauterine device is a single procedure that provides reliable, effective and long term contraception for many women. However, the insertion procedure can be associated with a troublesome degree of pain that prevent some women from choosing its use. Different interventions have been described to decrease pain perception during intrauterine device insertion with no agreement on an effective one.

Conditions

• IUCD Complication

Interventions

Type	Name	Description
DRUG	lidocaine patch	5% lidocaine patch applied at 3 hours before the procedure
DRUG	Sham patch	Sham patch containing no study medication applied 3 hours before the procedure

Timeline

• Start date: 2020-09-01
• Primary completion: 2021-08-31
• Completion: 2021-09-01
• First posted: 2020-08-19
• Last updated: 2020-09-21

Locations

1 site across 1 country: Egypt